Hutin Y J, Williams R J, Malfait P, Pebody R, Loparev V N, Ropp S L, Rodriguez M, Knight J C, Tshioko F K, Khan A S, Szczeniowski M V, Esposito J J
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
Emerg Infect Dis. 2001 May-Jun;7(3):434-8. doi: 10.3201/eid0703.010311.
Human monkeypox is a zoonotic smallpox-like disease caused by an orthopoxvirus of interhuman transmissibility too low to sustain spread in susceptible populations. In February 1997, 88 cases of febrile pustular rash were identified for the previous 12 months in 12 villages of the Katako-Kombe Health Zone, Democratic Republic of Congo (attack rate = 22 per 1,000; case-fatality rate = 3.7%). Seven were active cases confirmed by virus isolation. Orthopoxvirus- neutralizing antibodies were detected in 54% of 72 patients who provided serum and 25% of 59 wild-caught animals, mainly squirrels. Hemagglutination-inhibition assays and Western blotting detected antibodies in 68% and 73% of patients, respectively. Vaccinia vaccination, which protects against monkeypox, ceased by 1983 after global smallpox eradication, leading to an increase in the proportion of susceptible people.
人类猴痘是一种人畜共患的类似天花的疾病,由一种正痘病毒引起,人际传播能力极低,无法在易感人群中持续传播。1997年2月,在刚果民主共和国卡塔科-孔贝卫生区的12个村庄中,发现了前12个月内有88例发热性脓疱疹病例(发病率为每1000人中有22例;病死率为3.7%)。7例为病毒分离确诊的现患病例。在提供血清的72例患者中,54%检测到正痘病毒中和抗体,在59只野生捕获动物(主要是松鼠)中,25%检测到该抗体。血凝抑制试验和蛋白质印迹法分别在68%和73%的患者中检测到抗体。在全球根除天花后,于1983年停止了预防猴痘的牛痘接种,导致易感人群比例增加。